泌尿系统
抗生素
医学
中医药
随机对照试验
内科学
重症监护医学
传统医学
替代医学
微生物学
病理
生物
作者
GU Xiang-chen,Qiu Meisi,Lin Xie,Min Chen,Yueyi Deng,Zhang Changming,Jian Guihua,Wang Chen,Wang Yi
出处
期刊:PubMed Central
[National Institutes of Health]
日期:2024-06-01
卷期号:44 (3): 524-529
被引量:11
标识
DOI:10.19852/j.cnki.jtcm.20231024.001
摘要
OBJECTIVE: To systematically assess the effects of individualized Chinese medicines on recurrent urinary tract infections (rUTIs). METHODS: 116). Patients in the Chinese medicine group received individualized Chinese herbs, which were evaluated for syndrome differentiation. Patients in the control group received antibiotic treatment combined with a Chinese medicine placebo. The duration of treatment was three courses of four weeks each, with a three-month subsequent follow-up. UTI recurrence rate, Traditional Chinese Medicine (TCM) syndrome scores, 36-item Short Form Survey (SF-36) score, and urine secretory immunoglobulin A (SIgA) were measured and analyzed before and after treatment in each group. RESULTS: 0.05). The Chinese medicine group also demonstrated a significant increase in urine SIgA expression. CONCLUSION: Taken together, compared to the often-used long-term antimicrobial prophylaxis during the remission stage of rUTIs, treating patients with an individualized Chinese medicine decoction by syndrome differentiation could effectively reduce the recurrence rate, improve the patients' TCM syndrome scores and quality of life, and enhance immunity, which in turn helps to prevent antibiotic resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI